Generex, Docteur Andre Delforge SRL
Generex, Docteur Andre Delforge reported total assets of €1.53m at the end of the 2025 financial year (annual accounts filed with the NBB on 23 Sep 2026).
By total assets for 2025, Generex, Docteur Andre Delforge ranks among the 200 largest of the 500 companies in its sector (NACE 8691) in Belgium that filed accounts for that financial year. Largest companies in the sector →
The score of Generex, Docteur Andre Delforge shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +18 % Total assets +26 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Generex, Docteur Andre Delforge's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 23 Sep 2026
- Year ended 31 Dec 2024filed on 21 Aug 2025
- Year ended 31 Dec 2023filed on 23 Aug 2024
- Year ended 31 Dec 2022filed on 31 Aug 2023
- Year ended 31 Dec 2021filed on 18 Jul 2022
Generex, Docteur Andre Delforge's financial analysis
- Solvency85.8%sector median: 66.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Generex, Docteur Andre Delforge
Generex, Docteur Andre Delforge's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0477.025.511
- VAT number
- BE0477025511
- Peppol
- Registered · 0208:0477025511 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 05 Mar 2002
- Registered office
- 6698 Vielsalm
- Latest accounts
- 2025 · filed on 23 Sep 2026
- Activity
- Diagnostic imaging services and medical laboratory activities (NACE 86910)
Generex, Docteur Andre Delforge (SRL) has been based in Vielsalm since 2002, active in: diagnostic imaging services and medical laboratory activities. For 2025, it reports a net profit of 140,660 € and equity of €1.32m; its revenue is not published. Its solvency stands at 85.8%, above the median of its sector (66.2%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Generex, Docteur Andre Delforge
Companies in the same business, of comparable size and area, outside its group.
- Dr. Tim Decraecke, huisarts Diagnostic imaging services and medical laboratory activities Zwalm · balance sheet €1.27m
- Dokterspraktijk Joke Valkeneers Diagnostic imaging services and medical laboratory activities Peer · balance sheet 879,605 €
- Cabinet Médical MOREAU PONCELET - Médecine générale General medical practice activities Bièvre · balance sheet €1.47m
- Medisab Diagnostic imaging services and medical laboratory activities Onhaye · balance sheet 761,229 €
- Dr. BART DOSSCHE General medical practice activities Oudenaarde · balance sheet €1.66m
- Dr. Maris General medical practice activities Ninove · balance sheet €1.36m
- Dr. R. Blinder General medical practice activities Uccle · balance sheet €1.84m
- Dokter Yves Moubax Diagnostic imaging services and medical laboratory activities Lanaken · balance sheet 627,734 €
Frequently asked questions about Generex, Docteur Andre Delforge
What is the revenue of Generex, Docteur Andre Delforge?
Generex, Docteur Andre Delforge files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Generex, Docteur Andre Delforge?
In Belgium, the VAT number is the company number prefixed with BE: BE0477025511 for Generex, Docteur Andre Delforge, if the company is VAT-registered. Its company number (CBE) is 0477.025.511.
Where is the registered office of Generex, Docteur Andre Delforge?
According to the CBE register, the registered office of Generex, Docteur Andre Delforge is in 6698 Vielsalm.
What is the equity of Generex, Docteur Andre Delforge?
At the close of the 2025 financial year, the equity of Generex, Docteur Andre Delforge amounts to 1,315,222 €, a solvency of 85.8% of total assets.
Who manages Generex, Docteur Andre Delforge?
The register lists 1 active mandates at Generex, Docteur Andre Delforge. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
How large is Generex, Docteur Andre Delforge within its sector?
By total assets for 2025, Generex, Docteur Andre Delforge ranks among the 200 largest of the 500 companies in its sector (NACE 8691) in Belgium that filed accounts for that financial year.
The full file of Generex, Docteur Andre Delforge
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →